Artiva Biotherapeutics, Inc. (ARTV) Q1 2024 Earnings
ARTV·Reported August 29, 2024·Before market open
Artiva Biotherapeutics, Inc. reported Q1 2024 revenue of $251.0K. Diluted EPS came in at $-22.00, missed the $-4.40 consensus by $17.60.
Revenue
$251.0K
Diluted EPS
$-22.00missed by $17.60
Consensus: $-4.40
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q1 2024 Earnings FAQ
Common questions about Artiva Biotherapeutics, Inc.'s Q1 2024 earnings report.
Artiva Biotherapeutics, Inc. (ARTV) reported Q1 2024 earnings on August 29, 2024 before market open.
Artiva Biotherapeutics, Inc. reported revenue of $251.0K and diluted EPS of $-22.00 for Q1 2024.
EPS missed the consensus estimate of $-4.40 by $17.60.